Your browser doesn't support javascript.
Mapping the proteo-genomic convergence of human diseases.
Pietzner, Maik; Wheeler, Eleanor; Carrasco-Zanini, Julia; Cortes, Adrian; Koprulu, Mine; Wörheide, Maria A; Oerton, Erin; Cook, James; Stewart, Isobel D; Kerrison, Nicola D; Luan, Jian'an; Raffler, Johannes; Arnold, Matthias; Arlt, Wiebke; O'Rahilly, Stephen; Kastenmüller, Gabi; Gamazon, Eric R; Hingorani, Aroon D; Scott, Robert A; Wareham, Nicholas J; Langenberg, Claudia.
  • Pietzner M; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK.
  • Wheeler E; Computational Medicine, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany.
  • Carrasco-Zanini J; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK.
  • Cortes A; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK.
  • Koprulu M; GlaxoSmithKline, Stevenage SG1 2NY, UK.
  • Wörheide MA; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK.
  • Oerton E; Institute of Computational Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
  • Cook J; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK.
  • Stewart ID; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK.
  • Kerrison ND; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK.
  • Luan J; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK.
  • Raffler J; MRC Epidemiology Unit, Institute of Metabolic Science, University of Cambridge School of Clinical Medicine, Cambridge CB2 0QQ, UK.
  • Arnold M; Institute of Computational Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
  • Arlt W; Institut für Digitale Medizin, Universitätsklinikum Augsburg, 86156 Augsburg, Germany.
  • O'Rahilly S; Institute of Computational Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
  • Kastenmüller G; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC 27710, USA.
  • Gamazon ER; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham B15 2TT, UK.
  • Hingorani AD; MRC Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Scott RA; Institute of Computational Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
  • Wareham NJ; German Centre for Diabetes Research (DZD), 85764 Neuherberg, Germany.
  • Langenberg C; Vanderbilt Genetics Institute, Vanderbilt University Medical Center, Nashville, TN 37203, USA.
Science ; 374(6569): eabj1541, 2021 Nov 12.
Article in English | MEDLINE | ID: covidwho-1526448
ABSTRACT
Characterization of the genetic regulation of proteins is essential for understanding disease etiology and developing therapies. We identified 10,674 genetic associations for 3892 plasma proteins to create a cis-anchored gene-protein-disease map of 1859 connections that highlights strong cross-disease biological convergence. This proteo-genomic map provides a framework to connect etiologically related diseases, to provide biological context for new or emerging disorders, and to integrate different biological domains to establish mechanisms for known gene-disease links. Our results identify proteo-genomic connections within and between diseases and establish the value of cis-protein variants for annotation of likely causal disease genes at loci identified in genome-wide association studies, thereby addressing a major barrier to experimental validation and clinical translation of genetic discoveries.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Proteins / Proteins / Genome, Human / Disease / Proteome / Genomics Type of study: Etiology study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Female / Humans / Male Language: English Journal: Science Year: 2021 Document Type: Article Affiliation country: Science.abj1541

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Proteins / Proteins / Genome, Human / Disease / Proteome / Genomics Type of study: Etiology study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Female / Humans / Male Language: English Journal: Science Year: 2021 Document Type: Article Affiliation country: Science.abj1541